Navigation Links
Solutia Reports Third Quarter 2009 Results
Date:10/26/2009

ome (Loss) attributable to Solutia $(1.17) $(0.79) $13.91 ======= ======= ====== SOLUTIA INC. CONSOLIDATED STATEMENT OF FINANCIAL POSITION (Dollars in millions, except per share amounts) (Unaudited) Successor --------- September 30, December 31, 2009 2008 ---- ---- ASSETS Current Assets: Cash and cash equivalents $111 $32 Trade receivables, net of allowances of $1 in 2009 and $0 in 2008 268 227 Miscellaneous receivables 88 110 Inventories 273 341 Prepaid expenses and other assets 55 85 Assets of discontinued operations 6 490 --- --- Total Current Assets 801 1,285 Property, Plant and Equipment, net of accumulated depreciation of $111 in 2009 and $56 in 2008 931 952 Goodwill 511 511 Identified Intangible Assets, net 814 823 Other Assets 151 163 --- --- Total Assets $3,208
'/>"/>
SOURCE Solutia Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related biology technology :

1. Solutia Reports First Quarter 2009 Results
2. Solutia to Present at Deutsche Bank Small and Mid Cap Conference
3. Hanger Orthopedic Group, Inc. Reports an Increase of 30.4% in Earnings Per Share, to $0.30, for the Third Quarter 2009 and Raises Its 2009 Guidance
4. NuVasive Reports Third Quarter 2009 Financial Results
5. Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non-Alcoholic Steatohepatitis (NASH)
6. Fibrocell Science, Inc. Reports Outcome of FDA Advisory Committee Meeting on Azfibrocel-T for Wrinkles
7. Pieris Reports Preclinical Development Progress of its Next Generation VEGF Antagonist
8. Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial
9. Tianyin Pharmaceutical Co., Inc. Reports Record Fiscal 2009 Financials With $7.9 Million in Net Income
10. Neogen Reports 18% Increase in Net Income, 12% Increase in Revenues
11. Sinobiopharma Reports Highlights From Audited Financial Results for the Fiscal Year Ended May 31, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... developed a simple, cheap, accurate test to find undetected ... created a custom-made bacteria that glows green when it ... , The bacteria can be mixed into a colourless ... green patches to indicate the presence of landmines. ... to produce, could be delivered from the air onto ...
(Date:12/16/2009)... Md., Dec. 16 Martek Biosciences Corporation (Nasdaq: ... the fourth quarter and fiscal year ended October 31, ... down 3% from $90.4 million in the fourth quarter ... $0.33 per diluted share, for the fourth quarter of ... or $0.31 per diluted share, in last year,s fourth ...
(Date:12/16/2009)... -- Capitalizing on the continued strong ... active venture capital market, leaders from BioCrossroads, Eli ... Indiana University, Purdue University, the University of Notre ... today announced the establishment of the INext Fund, ... ,, Organized through BioCrossroads, Indiana,s initiative to grow, ...
(Date:12/16/2009)... has what scientists have been asking for! Zap-CHO is a ... and productivity of CHO cells. Developed for scientists seeking maximum ... defined and consistent recombinant CHO supplement. , ... ... Scientists working with CHO cells can now access an informational ...
Breaking Biology Technology:Martek Announces Fourth Quarter and FY 2009 Financial Results 2Martek Announces Fourth Quarter and FY 2009 Financial Results 3Martek Announces Fourth Quarter and FY 2009 Financial Results 4Martek Announces Fourth Quarter and FY 2009 Financial Results 5Martek Announces Fourth Quarter and FY 2009 Financial Results 6Martek Announces Fourth Quarter and FY 2009 Financial Results 7Martek Announces Fourth Quarter and FY 2009 Financial Results 8Martek Announces Fourth Quarter and FY 2009 Financial Results 9Martek Announces Fourth Quarter and FY 2009 Financial Results 10Martek Announces Fourth Quarter and FY 2009 Financial Results 11Martek Announces Fourth Quarter and FY 2009 Financial Results 12Martek Announces Fourth Quarter and FY 2009 Financial Results 13Martek Announces Fourth Quarter and FY 2009 Financial Results 14Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2
... Sanofi-aventis,U.S. launched today a new 200 mg single-use ... patients who have,adjuvant stage III colon cancer and ... convenience, efficiency and safety in the,preparation of the ... 50 mg and 100 mg single- use vials. ...
... Pharsight,s Diabetes Meta-Database to Quantify Competitive Treatment Landscape and ... ... MOUNTAIN VIEW, Calif., Aug. 27 Pharsight,Corporation (OTC Bulletin ... optimizing clinical drug development, today,announced that it has licensed its ...
... (Nasdaq: ANDS ), a biopharmaceutical company committed ... the treatment of,hepatitis C virus (HCV) infection and ... promoted to the position of President and Chief,Executive ... to pursue,other opportunities. Dr. Worland has also been ...
Other Biology Technology:New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation 2New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation 3New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation 4New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation 5New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation 6New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation 7Pharsight Achieves First License Sale for Public-Source Database 2Pharsight Achieves First License Sale for Public-Source Database 3Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer 2Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer 3
(Date:12/16/2009)... Scientists in Scotland, Canada and the US have ... for whale conservation. The team,s findings, published in ... protected areas, identified through feeding behaviour, can benefit ... , "There are enormous challenges associated with setting ... as whales," said lead author Erin Ashe, a ...
(Date:12/16/2009)... Steven Chu announced today the winners of the 2009 ... and development supporting the Department of Energy and its ... a gold medal, a citation and $50,000. ... DC early next year., "The contributions made by these ... of the United States are wide-ranging and meaningful," Secretary ...
(Date:12/16/2009)... Our cells, molecules form an intricate network of ... to measure individual molecular reactions outside the cells. ... than in the laboratory, scientists suspect that the ... substantially from external probes. We expected the cellular ... Professor Dieter Braun. "However, our novel optical approach ...
Breaking Biology News(10 mins):Zoning the ocean may help endangered whales to recover 2Zoning the ocean may help endangered whales to recover 3Secretary Chu announces 2009 Ernest Orlando Lawrence Award winners 2Looking for the heartbeat of cellular networks 2Infinite Mind Announces the Launch of a New Online Vision Therapy Program eyeQ 6512 1Infinite Mind Announces the Launch of a New Online Vision Therapy Program eyeQ 6512 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 6509 1CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 6509 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 6509 3Lotus Pharmaceuticals Inc to Exhibit at the 62nd PHARMCHINA 6506 1Lotus Pharmaceuticals Inc to Exhibit at the 62nd PHARMCHINA 6506 2
... botulism following cosmetic injections to the face indicates that ... resulted in toxin levels up to 40 times the ... the November 22/29 issue of JAMA. , Botulism ... of the spore-forming bacterium Clostridium botulinum and toxin-producing strains ...
... further than the air around you. It could be ... to a first-of-its-kind census of airborne microbes recently conducted ... Berkeley National Laboratory (Berkeley Lab). , The team ... in air samples taken from the Texas cities of ...
... conditions in flea carriers and mammal hosts, Pacific ... and likely proteins in the plague-bacterium Yersinia ... the disease’s virulence. , The team, led by ... Lipton and Kim Hixson, identified the proteins as ...
Other Biology News:Highly concentrated botulinum preparation for cosmetic injections can result in severe illness 2Highly concentrated botulinum preparation for cosmetic injections can result in severe illness 3Study finds the air rich with bacteria 2Study finds the air rich with bacteria 3Study finds the air rich with bacteria 4Plague proteome reveals proteins linked to infection 2
Immunogen: Synthetic peptide: S(399) P W S E L E F Q F P D D K D P V W E F(418) Storage: -20 C, Avoid Freeze/Thaw Cycles...
... Vector NTI Advance 9.1 ... and highly integrated application ... and molecular biology data ... readily available for export. ...
...
Borosilicate Glass. Certified for use with the Beacon 2000 Systems, 1,000 tubes/case...
Biology Products: